Ranbaxy crosses the billion dollar mark
By New Delhi: | 11 Mar 2004
According to a company statement, "In the year 1993, Ranbaxy enunciated its vision to become a $1-billion company by 2004. The credit for this successful achievement truly belongs to the combined efforts of the over 9,000-strong Ranbaxy family."
It is currently pursuing its goal of becoming a $5-billion company $5-billion company as part of the Garuda Vision. And to achieve this, Ranbaxy is spreading its wings across the globe. The company is selling its products in over 70 countries and has manufacturing operations in seven countries.
While
the international markets continue to be the focus area
for the company due to high margins, it will not lose
sight of the domestic business.
It plans to launch over 20 products this year and the
main therapeutic areas would be cardiovascular, anti-infective,
gastro-intestinal and central nervous system.